[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576094":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":51,"collaborators":18,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":57,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":18,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":77,"overallStatus":38,"whyStopped":18,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"National and Kapodistrian University of Athens","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Supplemental oxygen","ACTIVE_COMPARATOR","This group will receive supplemental oxygen in the form of a Venturi mask upon low oxygen saturation in oximetry (SaO2\\\u003C95%) and a nasal oxygen mask (in case of normal oxygen saturation) for the first 2 postoperative days",[13],"Behavioral: Supplemental oxygen therapy",{"label":15,"type":16,"description":17,"interventionNames":18},"Control group","NO_INTERVENTION","This group will not receive supplemental oxygen during the first two days of hospitalization",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Supplemental oxygen therapy","In this grou participants will receive supplemental oxygen in the form of a Venturi mask upon low oxygen saturation in oximetry (SaO2\\\u003C95%) and a nasal oxygen mask in all other cases during the first 2 postoperative days",[9],[26],{"name":27,"affiliation":5,"role":28},"Nikolaos Thomakos, Associate Professor","STUDY_DIRECTOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Vasilios Pergialiotis, Assistant Professor","CONTACT","+302132162291","pergialiotis@yahoo.com",[36],{"facility":37,"status":38,"city":39,"state":18,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"First department of Obstetrics and Gynecology","RECRUITING","Athens","11528","Greece","GR",{"type":44,"coordinates":45},"Point",[46,47],23.72784,37.98376,{"lat":47,"lon":46},[50],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Vasilios Pergialiotis","Assistant Professor","100576094","supplemental-high-flow-oxygen-to-reduce-infections-in-obese-gynecological-cancer-patients-100576094",false,"NCT06780813","Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients","Supplemental Administration of High Flow Oxygen to Enhance Postoperative Recovery and Reduce Infections in Obese Gynecological Cancer Patients","SAFE","Inclusion Criteria:\n\n* Obese (BMI\\>30kg\u002Fm2) gynecological cancer patients\n* Optimized preoperative CBC values (hemoglobin \\>11g\u002Fdl, WBC 4.000-11.000 X 109\u002FL, platelets 150,000 to 400,000 X 109\u002FL)\n* In the case of neoadjuvant therapy an interval longer than three weeks between the last cycle and the operation\n\nExclusion Criteria:\n\n* Active immunosuppresion\n* Preexisting infection of the abdominal wall\n* Preexisting sepsis","FEMALE","18 Years","85 Years",{"count":67,"type":68},400,"ESTIMATED","INTERVENTIONAL",[71],"NA","The incidence of surgical-site infection (SSI) and complications related to wound healing reaches 10-20% of gynecological cancer patients. Each complication may dramatically prolong the hospitalization period and increase the economic burden of hospital care. Appropriate wound care and tissue oxygenation are of special importance for wound healing. Assuming adequate perfusion, the easiest, safest, and most effective way to improve tissue oxygenation is to increase the fraction of inspired oxygen. However, there is considerable controversy as to whether supplemental oxygen actually reduces SSI and healing-related complications as to date, there is absence of relevant data.",[74,75,76],"Supplemental Oxygen","Gynecological Cancer","Surgical Site Infections",[9,78,79],"Surgical site infections","Gynecological cancer","2025-01-15",{"date":82,"type":83},"2025-01-17","ACTUAL",{"date":85,"type":83},"2025-01-10",{"date":87,"type":68},"2026-05-01",{"name":5,"class":6},1]